Este sitio está destinado sólo a profesionales de la salud facultados para prescribir en Chile y Perú, respectivamente

Búsqueda

Menu

Close

Iniciar SesiónCerrar SesiónProductos PfizerÁreas TerapéuticasRecursos PfizerContáctenos
Virus SincicialVirus Sincicial

Obtenga contenido y conozca más sobre los riesgos y consecuencias graves por el VSR

Conozca AbrysvoIndicacionesMaterno-infantilAdultos MayoresResumen de SeguridadEstudio Berni: RWE vacunación durante el embarazoContenido estudio Berni ChileContenido estudio Berni PerúQué es el VSRDescubra el VSRVSR en AdultosVSR en Niños y LactantesRecursosResumen de seguridad del producto ChileCovid-19COVID-19Conozca y obtenga contenido sobre esta enfermedadConozca más sobre los grupos de riesgoAdultos MayoresEmbarazadasPacientes con enfermedades cardiovascularesPacientes diabéticosPacientes con obesidadTecnología ARNmLos FundamentosLa AplicaciónEl PotencialRecursos ARNmConozca ComirnatyCovid Vaccine ChileComirnaty Education PerúNeumococoNeumococo

Example of description text sitting alongside header

Conozca Prevenar13IndicacionesRecomendacionesEficaciaInmunogenicidadResumen de Seguridad Prevenar13ChileEcuadorPerúConozca Prevenar20¿Qué es la Enfermedad Meningocócica?Factores de Riesgo¿Por qué Prevenar20?Esquemas de vacunaciónPrevenar20 PediátricoPrevenar20 AdultoResumen de SeguridadMeningococoMeningococo

Example of description text sitting alongside header

Conozca Nimenrix®IndicacionesRecomendacionesEficaciaInmunogenicidadConozca Trumenba®IndicacionesRecomendacionesEficaciaRazones para vacunarDescubra por qué debería vacunar a sus pacientes en ChileDescubra por qué debería vacunar a sus pacientes en PerúVaccine-NewsLo más reciente sobre vacunas en PerúMedCastMedCastClases Magistrales sobre vacunología
con Expertos del MundoConozca a los speakers y descubra sus charlasDr. Julio RamírezDr. Marco SáfadiDra. Claudia CortésDra. María Fernanda RodríguezDr. Rodrigo BlameyDra. Gianinna IzquierdoDr. Eduardo GotuzzoDr. Simón Nadel¿Por qué vacunar?¿Por qué vacunar?Importancia de la vacunaciónChile¿Por qué vacunar frente enfermedades respiratorias?Importancia de la vacunaciónPrincipales patologíasGrupos de Riesgo y recomendacionesPreguntas FrecuentesPerú¿Por qué vacunar frente enfermedades respiratorias?Importancia de la vacunaciónPrincipales patologíasGrupos de Riesgo y recomendacionesPreguntas FrecuentesRecursosRecursosEventosMaterialesVideosBibliotecas
Conozca más de cada enfermedad y descubra cómo puede ayudar a proteger a sus pacientes para el mañana

Riesgo de
enfermedad severa

Bajas tasas
de vacunación

Fomentar la confianza
en las vacunas

Riesgo de enfermedad severa

Las infecciones respiratorias pueden causar complicaciones significativas en adultos mayores de 65 años1-6

Referencias:
1. American Lung Association. RSV in adults. Updated July 10, 2025. Accessed July 14, 2025. https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/rsv-in-adults
2. American Lung Association. 9 things to know about pneumonia on World Pneumonia Day. Updated November 12, 2024. Accessed June 26, 2025. https://www.lung.org/blog/about-pneumonia-things-to-know
3. Centers for Disease Control and Prevention. Underlying conditions and the higher risk for severe COVID-19. Updated February 6, 2025. Accessed June 26, 2025. https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html
4. Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc. 2016;13(suppl 5):S422-S428.
5. Cong B, Dighero I, Zhang T, Chang A, Nair H, Li Y. Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis. BMC Med. 2023;21(1):224.
6. Zhang AJX, To KWK, Tse H, et al. High incidence of severe influenza among individuals over 50 years of age. Clin Vaccine Immunol. 2011;18(11):1918-1924.
7. Centers for Disease Control and Prevention. Adults schedule easy-read. Updated April 2025. Accessed July 14, 2025. https://www.cdc.gov/vaccines/imz-schedules/downloads/adults-schedule-easy-read.pdf
8. Abbadi A, Gentili S, Tsoumani E, et al. Impact of lower respiratory tract infections on healthcare utilization and mortality in older adults: a Swedish population based cohort study. Aging Clin Exp Res. 2024;36(1):146.

Los adultos mayores y las personas con afecciones médicas subyacentes tienen riesgo de sufrir desenlaces graves por infecciones respiratorias1-7

EPOC=enfermedad pulmonar obstructiva crónica.

Referencias:
1. American Lung Association. RSV in adults. Updated July 10, 2025. Accessed July 14, 2025. https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/rsv-in-adults
2. American Lung Association. 9 things to know about pneumonia on World Pneumonia Day. Updated November 12, 2024. Accessed June 26, 2025. https://www.lung.org/blog/about-pneumonia-things-to-know
3. Centers for Disease Control and Prevention. Underlying conditions and the higher risk for severe COVID-19. Updated February 6, 2025. Accessed June 26, 2025. https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html
4. Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc. 2016;13(suppl 5):S422-S428.
5. Ghaswalla P, Hitchens A, Candrilli SD, et al. Prevalence of underlying conditions associated with higher risk for severe RSV, influenza, or COVID-19 in adults in the United States, 2017-2018. Session 63: Virology: studies of the epidemiology of viral infections. Presented October 12, 2023.
6. Grant LR, Meche A, McGrath L, et al. Risk of pneumococcal disease in US adults by age and risk profile. Open Forum Infect Dis. 2023;10(5):ofad192.
7. Mallah N, Urbieta AD, Rivero-Calle I, et al. New vaccines for chronic respiratory patients. Arch Bronconeumol. 2024;60(9):565-575.
8. Centers for Disease Control and Prevention. Adults schedule easy-read. Updated April 2025. Accessed July 14, 2025.    https://www.cdc.gov/vaccines/imz-schedules/downloads/adults-schedule-easy-read.pdf
9. Abbadi A, Gentili S, Tsoumani E, et al. Impact of lower-respiratory tract infections on healthcare utilization and mortality in older adults: a Swedish population-based cohort study. Aging Clin Exp Res. 2024;36(1):146.
10. Paget J, Staadegaard L , Wang X, et al. Global and national influenza-associated hospitalisation rates: estimates for 40 countries and administrative regions. J Glob Health. 2023;13:04003.
11. Palmer S, Cunniffe N, Donnelly R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J R Soc Interface. 2021;18(176):20200982.
12. Gil-Prieto R, Pascual-Garcia R, Walter S, Álvaro-Meca A, Gil-De-Miguel Á. Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study. Hum Vaccin Immunother. 2016;12(7):1900-1905.
13. European Society of Cardiology Press Office. Vaccination as a new form of cardiovascular prevention: an ESC Clinical Consensus Statement. Published June 30, 2025. Accessed July 30, 2025. https://www.escardio.org/The-ESC/Press-Office/Press-releases/vaccination-as-a-new-form-of-cardiovascular-prevention-an-esc-clinical-consensus#

A pesar de los beneficios de las vacunas, muchos pacientes mayores elegibles siguen sin vacunarse1

Referencias:
1. Maggi S, Launay O, Dawson R. Respiratory virus vaccines: pathways to recommendations and enhanced coverage for at‑risk populations. Infect Dis Ther. 2025;14(suppl 1):S99-S114.
2. World Health Organization. Keeping safe from COVID-19, influenza, and respiratory syncytial virus (RSV) this autumn and winter. Protecting lives. Strengthening health systems. Updated September 29, 2023-March 30, 2024. Accessed June 26, 2025. https://www.who.int/europe/news-room/events/item/2023/09/29/default-calendar/keeping-safe-from-covid-19--influenza--and-respiratory-syncytial-virus-(rsv)-this-autumn-and-winter.-protecting-lives.-strengthening-health-systems  
3. Centers for Disease Control and Prevention. Explaining how vaccines work. Updated August 10, 2024. Accessed July 29, 2025. https://.cdc.gov/vaccines/basics/explaining-how-vaccines-work.html
4. Root-Bernstein R. Pneumococcal and influenza vaccination rates and pneumococcal invasive disease rates set geographical and ethnic population susceptibility to serious COVID-19 cases and deaths. Vaccines (Basel). 2021;9(5):474.
5. Averin A, Huebbe B, Atwood M, et al. Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany. Expert Rev Vaccines. 2025;24(1):1-10.
6. European Centre for Disease Prevention and Control. Surveillance report on interim COVID-19 vaccination coverage in the EU/EEA, August 2024 – January 2025. Updated February 2025. Accessed June 26, 2025. https://www.ecdc.europa.eu/sites/default/files/documents/ECDC_COVID-19Vaccination_Aug24_Jan25.pdf
7. [Local health authority].
8. World Health Organization. Ten threats to global health in 2019. Updated August 23, 2021. Accessed June 26, 2025. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019

Recomendaciones de vacunación contra infecciones respiratorias para adultos de 18 años o más1

Referencias:
1. [Autoridad sanitaria local].
2. Centers for Disease Control and Prevention. About influenza. Updated August 13, 2024. Accessed July 24, 2025. https://www.cdc.gov/flu/about/index.html
3. Centers for Disease Control and Prevention. Adults schedule easy-read. Updated April 2025. Accessed July 14, 2025. https://www.cdc.gov/vaccines/imz-schedules/downloads/adults-schedule-easy-read.pdf
4. Centers for Disease Control and Prevention. About pneumococcal disease. Updated October 31, 2024. Accessed July 14, 2025. https://www.cdc.gov/pneumococcal/about/index.html
5. [National Center for Immunization and Respiratory Diseases. Immunization can prevent severe respiratory illness and death. Updated October 11, 2024. Accessed July 24, 2025. https://www.cdc.gov/ncird/whats-new/immunization-can-prevent-severe-respiratory-illness-and-death.html]
6. [Centers for Disease Control and Prevention. RSV vaccine guidance for adults. Updated July 8, 2025. Accessed July 24, 2025. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html]
7. [Centers for Disease Control and Prevention. Pneumococcal vaccination. Updated October 26, 2024. Accessed July 24, 2025. https://www.cdc.gov/pneumococcal/vaccines/index.html]
8. [Centers for Disease Control and Prevention. Pneumococcal disease: causes and how it spreads. Updated February 14, 2024. Accessed July 24, 2025. https://www.cdc.gov/pneumococcal/causes/index.html]

Como profesional de la salud, usted es una fuente confiable de información sanitaria para sus pacientes1

Su recomendación es el factor más importante para que sus pacientes se vacunen1

Referencias:
1. Centers for Disease Control and Prevention. Adult immunization standards. Updated August 9, 2024. Accessed June 26, 2025. https://www.cdc.gov/vaccines-adults/hcp/imz-standards/index.html
2. Centers for Disease Control and Prevention. Vaccine safety. Updated February 25, 2020. Accessed June 26, 2025. https://www.cdc.gov/patient-safety/about/index.html
3. International Coalition of Medicines Regulatory Authorities. ICMRA statement about confidence in vaccine safety and effectiveness (for healthcare professionals). Issued 2025. Accessed July 10, 2025.
4. Yu X, Wang H, Ma S, Chen W, Sun L, Zou Z. Estimating the global and regional burden of lower respiratory infections attributable to leading pathogens and the protective effectiveness of immunization programs. Int J Infect Dis. 2024;149:107268.
5. World Health Organization. How do vaccines work? Updated February 25, 2025. Accessed June 26, 2025. https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work 6. Davidson JA, Banerjee A, Smeeth L, et al. Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study. Lancet Digit Health. 2021;3(12):e773-e783.

Elabore
un plan de vacunación

Un plan de vacunación puede ayudar a aumentar la aceptación de las vacunas1,2

Referencias: 1. Centers for Disease Control and Prevention. Adult immunization standards. Updated August 9, 2024. Accessed June 26, 2025. https://www.cdc.gov/vaccines-adults/hcp/imz-standards/index.html 2. Bonnani P, Steffen R, Schelling J. Vaccine co-administration in adults: an effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023;19(1):2195786.

Un plan de vacunación puede ayudar a aumentar la aceptación de las vacunas1,2

Referencias:
1. Bonnani P, Steffen R, Schelling J. Vaccine co-administration in adults: an effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023;19(1):2195786.
2. Bonnani P, Steffen R, Schelling J. Vaccine co-administration in adults: an effective way to improve vaccination coverage. Hum VaccinImmunother. 2023;19(1):2195786.
3. Centers for Disease Control and Prevention. Getting a flu vaccine and other recommended vaccines at the same time. Updated September 17, 2024. Accessed June 26, 2025. https://www.cdc.gov/flu/vaccines/coadministration.htm

Todos los derechos reservados © 2026 Pfizer Chile S.A y Pfizer S.A Perú. La información contenida en este sitio web tiene exclusivamente propósitos académicos e informativos para profesionales de la salud facultados para prescribir. Prohibida su reproducción total o parcial sin autorización de su titular. Para más información consultar con el Departamento de Información Médica de Pfizer en el siguiente link.

PfizerPro Andino - Código interno de aprobación:

PP-UNP-CHL-2516

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Hac habitasse platea dictumst quisque sagittis purus sit amet volutpat. Lectus magna fringilla urna porttitor rhoncus. Venenatis urna cursus eget nunc scelerisque viverra. Id donec ultrices tincidunt arcu non sodales.

Sagittis aliquam malesuada bibendum arcu vitae elementum curabitur. Pellentesque elit ullamcorper dignissim cras tincidunt. Orci ac auctor augue mauris augue neque. Dui vivamus arcu felis bibendum ut tristique et egestas quis. Sed vulputate mi sit amet mauris commodo.

Nunc eget lorem dolor sed viverra ipsum. Sed ullamcorper morbi tincidunt ornare.

Está siendo dirigido a un sitio web externo a:

https://www.pfizerproandino.com

Este enlace ha sido provisto por ser de interés. Por favor tome en cuenta que este sitio web no pertenece ni es controlado por PfizerPro; tampoco está sujeto a nuestra política de privacidad.
Usted Está Saliendo de PfizerPro Usted está saliendo de PfizerPro y será redireccionado a nuestro proveedor para completar su registro. Cualquier información personal que usted encuentre previamente llena de su perfil en PfizerPro o que usted provea será manejada de acuerdo a nuestra Política de Privacidad.  Sus datos no serán usados para otro propósito.